H2O2-triggered bubble generating antioxidant polymeric nanoparticles as ischemia/reperfusion targeted...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Materials Science

Background:

• Reactive oxygen species (ROS), particularly hydrogen peroxide (H2O2), are key mediators of oxidative stress, inflammation, and cellular damage in conditions like ischemia/reperfusion (I/R) injury.
• H2O2 is a stable and abundant ROS, making it a potential diagnostic biomarker and therapeutic target for oxidative stress-related diseases.
• Current treatments for I/R injury often lack targeted delivery and dual functionality for imaging and therapy.

Purpose of the Study:

• To develop a novel nanotheranostic agent for simultaneous ultrasound imaging and therapeutic intervention in hepatic I/R injury.
• To investigate the H2O2-triggered CO2-generating capabilities of poly(vanillin oxalate) (PVO) nanoparticles for bubble generation and therapeutic effects.
• To evaluate the efficacy of PVO nanoparticles in enhancing ultrasound signals and mitigating liver damage associated with I/R injury.

Main Methods:

• Synthesis of poly(vanillin oxalate) (PVO) nanoparticles designed to generate CO2 in response to H2O2.
• Evaluation of H2O2-triggered CO2 generation and release of vanillin, an antioxidant and anti-inflammatory agent.
• Intravenous administration of PVO nanoparticles in a model of hepatic I/R injury.
• Assessment of ultrasound imaging enhancement at the injury site.
• Analysis of liver damage, inflammation, and apoptosis following PVO nanoparticle treatment.

Main Results:

• PVO nanoparticles successfully generated CO2 bubbles upon encountering H2O2, enhancing ultrasound signals.
• Intravenous administration of PVO nanoparticles significantly suppressed liver damage in hepatic I/R injury.
• PVO nanoparticles effectively inhibited inflammation and apoptosis in the injured liver tissue.
• This represents the first H2O2-responsive platform combining ultrasound contrast generation with therapeutic antioxidant and anti-inflammatory activities.

Conclusions:

• H2O2-responsive PVO nanoparticles serve as a novel theranostic platform for ultrasound imaging and treatment of oxidative stress-related diseases.
• The dual functionality of PVO nanoparticles, offering both diagnostic imaging and therapeutic benefits, holds significant promise for managing hepatic I/R injury.
• This technology has broad potential applications in diagnosing and treating other diseases associated with elevated H2O2 levels.